Scientia Clinical Research（SCR）是一家通過美國 FDA 審核的臨床研究機構，專門承接製藥與生技公司早期階段臨床試驗。

試驗類型包括：首次人體試驗（First-time-in-human）、首次病人試驗（First-time-in-patient）、單劑量／多劑量遞增試驗（SAD/MAD）、概念驗證試驗（Proof of Concept）、藥物動力學／藥效學（PK/PD）研究、食物效應試驗、藥物交互作用研究、QTc 延長風險評估（thorough QTc）、民族藥理學研究、劑型開發研究（我們現場設有 Grade C 製劑生產區）、各類特殊試驗（可整合多項藥效學指標，如流式細胞儀與細胞激素分析）。
 
擁有涵蓋小分子與生物製劑的豐富經驗，應用於多種治療領域。

Scientia Clinical Research (SCR) is FDA audited and specialises in early phase clinical trials for pharmaceutical and biotech companies.

Our studies include first-time-in-human, first-time-in-patient, single and multiple ascending dose studies (SAD/MAD), proof of concept studies, PK/PD studies, food effect studies, drug interaction studies, thorough QTc studies, ethno pharmacology studies, formulation studies (Grade C manufacturing suite onsite) and specialty studies incorporating a range of pharmacodynamic markers such as flow cytometry and cytokine analysis.

We have experience with both small molecules and biologics across a wide range of therapeutic areas.